Skip to main content

Table 2 Overall frequency of antimicrobial resistant E. coli from community-onset vs healthcare-onset/associated bacteriuria episodes, 2014–2020

From: Trends in prevalence of extended-spectrum beta-lactamase-producing Escherichia coli isolated from patients with community- and healthcare-associated bacteriuria: results from 2014 to 2020 in an urban safety-net healthcare system

  Number of antimicrobial resistant E. coli bacteriuria episodes, n (%)
NIT T/S CIP ESBL Any AMR MDR
Community onset* 129 (2) 2691 (35) 1537 (20) 623 (8) 4719 (61) 1306 (16.85)
Healthcare onset/associated** 42 (3) 544 (43) 496 (39) 308 (24) 911 (71) 401 (31.30)
  1. Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance. Not all ESBL-E. coli samples were tested for NIT, T/S or CIP
  2. *7751 isolates tested for ESBL, Any AMR, or MDR, 7737 for T/S and CIP, 7736 tested for NIT
  3. **1277 isolates tested for ESBL, Any AMR, or MDR, 1274 for T/S and CIP, 1273 for NIT